Search Results - "Boggio, Katia"
-
1
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas
Published in The Journal of clinical investigation (01-04-2003)“…Since the mechanisms by which specific immunity destroys Her-2/neu carcinoma cells are highly undetermined, these were assessed in BALB/c mice vaccinated with…”
Get full text
Journal Article -
2
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice
Published in The Journal of experimental medicine (03-08-1998)“…The ability of interleukin (IL)-12 to prevent tumors when administered to individuals with a genetic risk of cancer was studied in two lines of transgenic mice…”
Get full text
Journal Article -
3
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice
Published in The Journal of immunology (1950) (01-11-2000)“…The ability of vaccination with plasmids coding for the extracellular and the transmembrane domain of the product of transforming rat Her-2/neu oncogene…”
Get full text
Journal Article -
4
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin
Published in Laboratory investigation (01-10-1999)“…Morphologic examinations of mammary neoplasias arising in BALB/c (H-2d) mice carrying the activated rat HER-2/neu oncogene (BALB-NeuT), and in FVB (H-2q) mice…”
Get more information
Journal Article -
5
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice
Published in Cancer research (Chicago, Ill.) (15-01-2000)“…Previous studies in mice have shown that chronic administration of recombinant interleukin-12 (IL-12) hampers the progression of both chemical- and…”
Get full text
Journal Article -
6
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
Published in Cancer research (Chicago, Ill.) (01-04-2001)“…With a slight asynchronous but consistent progression, all of the mammary glands of female BALB/c mice transgenic for the transforming rat HER-2/neu oncogene…”
Get full text
Journal Article -
7
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice
Published in Clinical cancer research (01-03-2001)“…Because BALB/c mice transgenic for the rat Her-2/neu oncogene develop multifocal carcinomas in all mammary glands by week 33, they constitute an aggressive…”
Get full text
Conference Proceeding Journal Article -
8
Inhibition of Mammary Carcinogenesis by Systemic Interleukin 12 or pl85neu DNA Vaccination in Her-2/neu Transgenic BALB/c Mice
Published in Clinical cancer research (01-03-2001)“…Because BALB/c mice transgenic for the rat Her-2/ neu oncogene develop multifocal carcinomas in all mammary glands by week 33, they constitute an aggressive…”
Get full text
Journal Article -
9
The dream of effective cytokine-based tumor vaccines
Published in European cytokine network (Montrouge) (01-09-1997)Get more information
Journal Article -
10
Cytokine gene-engineered vaccines
Published in Current opinion in molecular therapeutics (01-02-1999)“…Cytokines modulate immune reactivity and have therefore been used to build cancer vaccines. Experimental vaccination of rodents and humans with cytokine-gene…”
Get more information
Journal Article